BTK inhibitor CNX-774, Purity ≥98%

Cat. No.: X24-06-ZQ440

BTK inhibitor CNX-774, Purity ≥98%

Synonym: 1202759-32-7; BTK inhibitor; CNX 774; CNX774

  • CAS Number: 1202759-32-7
  • Compound CID: 59174579
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CNX-774, soluble in DMSO and ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells. It targets BTK.
Molecular Weight
499.5
Molecular Formula
C26H22FN7O3
Targets
BTK: <1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (178.18 mM); Water: Insoluble; Ethanol: 2 mg/mL (4 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
CNX-774 facilitates research on inhibiting BTK for potential impacts on autoimmune disease treatment strategies.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0